Response to cholinesterase inhibitors affects lifespan in Alzheimer’s disease

BACKGROUND: A varying response to cholinesterase inhibitor (ChEI) treatment has been reported among patients with Alzheimer’s disease (AD). Whether the individual-specific response, specific ChEI agent or dose affects mortality is unclear. We aimed to examine the relationship between the 6-month res...

Descripción completa

Detalles Bibliográficos
Autores principales: Wattmo, Carina, Londos, Elisabet, Minthon, Lennart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172846/
https://www.ncbi.nlm.nih.gov/pubmed/25213579
http://dx.doi.org/10.1186/s12883-014-0173-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172846/
https://www.ncbi.nlm.nih.gov/pubmed/25213579
http://dx.doi.org/10.1186/s12883-014-0173-4

Ejemplares similares